Results 1 to 10 of about 316,555 (354)
Antifungal Activity of 5-Fluorouridine Against <i>Candida albicans</i> and <i>Candida parapsilosis</i> Based on Virulence Reduction. [PDF]
Lenarczyk E, Oleksiak D, Janeczko M.
europepmc +1 more source
Characterization of Hydrogel Beads for the Gradual Release of <i>Origanum vulgare</i> L. Essential Oil and Evaluation of Their Antifungal Activity Against <i>Candida albicans</i>. [PDF]
Concha V +4 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Active packaging with antifungal activities
International Journal of Food Microbiology, 2016There have been many reviews concerned with antimicrobial food packaging, and with the use of antifungal compounds, but none provided an exhaustive picture of the applications of active packaging to control fungal spoilage. Very recently, many studies have been done in these fields, therefore it is timely to review this topic. This article examines the
Nguyen van Long, Nicolas +2 more
openaire +4 more sources
Antifungal activity of transferrin
Medical Mycology, 1979Inhibitory effects of transferrin on fungal growth were successfully estimated by measuring fungal ATP content. By this method, it was demonstrated that both human and rabbit transferrin possessed the inhibitory effect in the absence of any other factor on yeast-like and filamentous fungi.
Akio Shiraishi, Tadashi Arai
openaire +3 more sources
Antifungal activity of wogonin
Phytotherapy Research, 2003AbstractThe antifungal activity of the wogonin isolated from Holmskioldia sanguinea Retz was determined on four different fungal organisms. The pure compound wogonin significantly inhibited the growth of Aspergillus niger, Penicillium frequentance, P. notatum and Botrytis cinerea, in a concentration dependent fashion, when tested by turbidity and spore ...
Mahesh Pal +4 more
openaire +3 more sources
Antifungal activity of nontraditional antifungal agents
Current Fungal Infection Reports, 2009Invasive fungal infections are becoming increasingly important in the management of critically ill and immunocompromised patients. As organ and stem cell transplantation becomes more prominent and immune therapies are employed for diseases such as rheumatoid arthritis and plaque psoriasis, the population of patients at risk continues to grow.
Craig A. Martin, William R. Judd
openaire +2 more sources

